85.20
price up icon1.41%   1.045
 
loading
前日終値:
$84.16
開ける:
$85
24時間の取引高:
260.10K
Relative Volume:
0.21
時価総額:
$2.88B
収益:
$55.23M
当期純損益:
$-164.08M
株価収益率:
-12.45
EPS:
-6.8461
ネットキャッシュフロー:
$-208.68M
1週間 パフォーマンス:
+2.58%
1か月 パフォーマンス:
+14.22%
6か月 パフォーマンス:
+54.83%
1年 パフォーマンス:
+13,193%
1日の値動き範囲:
Value
$83.66
$86.33
1週間の範囲:
Value
$82.15
$88.10
52週間の値動き範囲:
Value
$0.57
$109.00

Nektar Therapeutics Stock (NKTR) Company Profile

Name
名前
Nektar Therapeutics
Name
セクター
Healthcare (1107)
Name
電話
(415) 482-5300
Name
住所
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Name
職員
63
Name
Twitter
@nektarnews
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
NKTR's Discussions on Twitter

Compare NKTR vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
NKTR icon
NKTR
Nektar Therapeutics
85.24 2.84B 55.23M -164.08M -208.68M -6.8461
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
425.19 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
720.55 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
811.76 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
303.29 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
315.86 33.06B 5.36B 287.73M 924.18M 2.5229

Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-24 開始されました Wedbush Neutral
2026-03-17 開始されました TD Cowen Buy
2026-02-10 アップグレード William Blair Mkt Perform → Outperform
2025-11-26 開始されました Citigroup Buy
2025-06-24 繰り返されました BTIG Research Buy
2025-06-24 繰り返されました H.C. Wainwright Buy
2025-04-11 アップグレード Jefferies Hold → Buy
2025-03-14 アップグレード Oppenheimer Perform → Outperform
2025-01-08 開始されました B. Riley Securities Buy
2024-12-10 開始されました H.C. Wainwright Buy
2024-11-04 開始されました Piper Sandler Overweight
2024-09-30 再開されました BTIG Research Buy
2024-06-28 開始されました Rodman & Renshaw Buy
2023-11-20 再開されました JP Morgan Underweight
2023-11-09 アップグレード TD Cowen Market Perform → Outperform
2023-05-10 アップグレード Jefferies Underperform → Hold
2023-02-24 ダウングレード Jefferies Hold → Underperform
2022-08-08 ダウングレード JP Morgan Neutral → Underweight
2022-05-31 再開されました Jefferies Hold
2022-04-18 ダウングレード Goldman Neutral → Sell
2022-03-15 ダウングレード Cowen Outperform → Market Perform
2022-03-15 ダウングレード Mizuho Buy → Neutral
2022-03-14 ダウングレード BTIG Research Buy → Neutral
2022-03-14 ダウングレード BofA Securities Neutral → Underperform
2022-03-14 ダウングレード Stifel Buy → Hold
2022-03-14 ダウングレード William Blair Outperform → Mkt Perform
2022-03-09 アップグレード Oppenheimer Perform → Outperform
2021-11-08 アップグレード The Benchmark Company Hold → Buy
2021-09-10 開始されました BofA Securities Neutral
2021-06-28 アップグレード Stifel Hold → Buy
2021-05-18 再開されました Goldman Neutral
2021-02-22 ダウングレード The Benchmark Company Buy → Hold
2021-01-06 開始されました Stifel Hold
2020-09-14 開始されました JP Morgan Neutral
2020-06-10 ダウングレード CFRA Hold → Sell
2020-05-12 繰り返されました H.C. Wainwright Neutral
2020-04-22 開始されました The Benchmark Company Buy
2020-03-30 アップグレード Goldman Sell → Neutral
2020-03-04 開始されました Barclays Overweight
2020-02-03 アップグレード Mizuho Neutral → Buy
2019-10-24 開始されました Oppenheimer Perform
2019-10-08 ダウングレード Goldman Buy → Sell
2019-08-09 ダウングレード JP Morgan Overweight → Neutral
2019-08-09 ダウングレード Jefferies Buy → Hold
2019-08-09 ダウングレード Mizuho Buy → Neutral
2019-03-15 開始されました SVB Leerink Mkt Perform
2018-12-13 開始されました Goldman Buy
2018-06-11 ダウングレード H.C. Wainwright Buy → Neutral
2018-06-04 繰り返されました H.C. Wainwright Buy
2018-04-20 開始されました Seaport Global Securities Buy
2018-04-13 再開されました Piper Jaffray Overweight
2018-04-06 繰り返されました Mizuho Buy
2018-04-02 再開されました H.C. Wainwright Buy
すべてを表示

Nektar Therapeutics (NKTR) 最新ニュース

pulisher
May 05, 2026

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who - GlobeNewswire

May 05, 2026
pulisher
May 05, 2026

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

May 05, 2026
pulisher
May 05, 2026

Nektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still Cheap - Seeking Alpha

May 05, 2026
pulisher
May 05, 2026

NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - ChartMill

May 05, 2026
pulisher
May 05, 2026

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Nektar Therapeutics LawsuitNKTR - PR Newswire

May 05, 2026
pulisher
May 04, 2026

NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit - PR Newswire

May 04, 2026
pulisher
May 04, 2026

NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics and Encourages Investors to Contact the Firm Before May 5th - Scott Coop

May 04, 2026
pulisher
May 04, 2026

Did Fast Track Rezpegaldesleukin Data and New Hires Just Shift Nektar Therapeutics' (NKTR) Investment Narrative? - simplywall.st

May 04, 2026
pulisher
May 04, 2026

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - GlobeNewswire Inc.

May 04, 2026
pulisher
May 04, 2026

NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & - GlobeNewswire

May 04, 2026
pulisher
May 04, 2026

NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

Deadline Soon: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - ChartMill

May 04, 2026
pulisher
May 04, 2026

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

May 04, 2026
pulisher
May 03, 2026

NKTR DEADLINE NOTICE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Nektar Therapeutics ... - Caledonian Record

May 03, 2026
pulisher
May 03, 2026

NKTR DEADLINE NOTICE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - GlobeNewswire Inc.

May 03, 2026
pulisher
May 03, 2026

Why Nektar Therapeutics Stock Rocked it Today - MSN

May 03, 2026
pulisher
May 03, 2026

A Look At Nektar Therapeutics (NKTR) Valuation After New REZOLVE AA Data Funding And Phase 3 Plans - simplywall.st

May 03, 2026
pulisher
May 02, 2026

How The Rezpegaldesleukin Story Is Recasting The Narrative For Nektar Therapeutics (NKTR) - Yahoo Finance

May 02, 2026
pulisher
May 01, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

May 01, 2026
pulisher
May 01, 2026

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

May 01, 2026
pulisher
May 01, 2026

NKTR UPCOMING DEADLINE : The Gross Law Firm Alerts Nektar - GlobeNewswire

May 01, 2026
pulisher
May 01, 2026

NKTR Stock Price, Quote & Chart | NEKTAR THERAPEUTICS (NASDAQ:NKTR) - ChartMill

May 01, 2026
pulisher
May 01, 2026

Nektar Therapeutics adds to its 129% two-month run with alopecia news - MSN

May 01, 2026
pulisher
Apr 30, 2026

Nektar Therapeutics (NKTR) price target increased by 12.59% to 147.14 - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics and Certain OfficersNKTR - PR Newswire

Apr 30, 2026
pulisher
Apr 30, 2026

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsui - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

NKTR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to ... - Caledonian Record

Apr 30, 2026
pulisher
Apr 30, 2026

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Apr 30, 2026
pulisher
Apr 30, 2026

NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - Morningstar

Apr 30, 2026
pulisher
Apr 30, 2026

NEKTAR THERAPEUTICS (NKTR) SHAREHOLDER ALERTBernstein - GlobeNewswire

Apr 30, 2026
pulisher
Apr 30, 2026

Nektar Therapeutics (NKTR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

United StatesGoodwin Guides Nektar Therapeutics On Its $373.8 Million Underwritten Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares - Mondaq

Apr 30, 2026
pulisher
Apr 29, 2026

NEKTAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class ActionNKTR - TMX Newsfile

Apr 29, 2026
pulisher
Apr 29, 2026

MSN - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

SHAREHOLDER ALERT Securities Class Action Filed Against Nektar Therapeutics (NKTR) - TMX Newsfile

Apr 29, 2026
pulisher
Apr 29, 2026

Moody Aldrich Partners LLC Decreases Stock Position in Nektar Therapeutics $NKTR - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets - BioSpace

Apr 29, 2026
pulisher
Apr 29, 2026

Nektar to Announce Financial Results for the First Quarter on Th - GuruFocus

Apr 29, 2026
pulisher
Apr 28, 2026

Why Nektar Therapeutics (NKTR) Is Down 8.6% After Raising Capital And Reporting New Alopecia Data - Sahm

Apr 28, 2026
pulisher
Apr 28, 2026

ROSEN, LEADING GLOBAL COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action- NKTR - TMX Newsfile

Apr 28, 2026
pulisher
Apr 28, 2026

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm - Morningstar

Apr 28, 2026
pulisher
Apr 28, 2026

Portnoy Law Firm Announces Class Action on Behalf of Nektar Therapeutics, Inc. Investors - GlobeNewswire

Apr 28, 2026
pulisher
Apr 28, 2026

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Apr 28, 2026
pulisher
Apr 28, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Apr 28, 2026
pulisher
Apr 27, 2026

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 27, 2026
pulisher
Apr 27, 2026

NKTR Investor Alert: Nektar Therapeutics Securities Fraud - GlobeNewswire

Apr 27, 2026
pulisher
Apr 27, 2026

Nektar posts 52-week data from mid-stage trial for hair loss therapy - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Nektar Therapeutics prices $400M stock offering - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Why Nektar Therapeutics Shares Are Sinking Today - TipRanks

Apr 27, 2026
pulisher
Apr 27, 2026

NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe

Apr 27, 2026
pulisher
Apr 27, 2026

NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Th - GuruFocus

Apr 27, 2026

Nektar Therapeutics (NKTR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.50
price up icon 0.78%
$50.76
price up icon 2.57%
$92.69
price down icon 3.01%
$138.73
price down icon 1.11%
$147.88
price down icon 0.02%
ONC ONC
$305.60
price up icon 2.86%
大文字化:     |  ボリューム (24 時間):